Functions and biosynthesis of plasmalogens in health and disease.
暂无分享,去创建一个
[1] R. Wanders,et al. Chondrodysplasia punctata with a mild clinical course , 1994, Journal of Inherited Metabolic Disease.
[2] R. Wanders,et al. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata. , 1993, Clinical chemistry.
[3] P. Devaux,et al. Transmembrane distribution and translocation of spin-labeled plasmalogens in human red blood cells. , 1993, Chemistry and physics of lipids.
[4] P. Vreken,et al. Plasmalogen phospholipids are involved in HDL-mediated cholesterol efflux: insights from investigations with plasmalogen-deficient cells. , 1998, Biochemical and biophysical research communications.
[5] H. Moser,et al. Peroxisomal Disorders: Genotype, Phenotype, Major Neuropathologic Lesions, and Pathogenesis , 1998 .
[6] Burton J. Litman,et al. Optimization of Receptor-G Protein Coupling by Bilayer Lipid Composition I , 2001, The Journal of Biological Chemistry.
[7] H. van den Bosch,et al. Topography of ether phospholipid biosynthesis. , 1989, Biochimica et biophysica acta.
[8] H. Moser,et al. Ether lipid biosynthesis: alkyl-dihydroxyacetonephosphate synthase protein deficiency leads to reduced dihydroxyacetonephosphate acyltransferase activities. , 1999, Journal of lipid research.
[9] T. Lee,et al. Biosynthesis and possible biological functions of plasmalogens. , 1998, Biochimica et biophysica acta.
[10] R. Catalán,et al. Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by ceramide. , 2003, European journal of biochemistry.
[11] L. Horrocks,et al. Lysoplasmalogenase: solubilization and partial purification from liver microsomes. , 1991, Methods in enzymology.
[12] H. Waterham,et al. Identification of PEX7 as the second gene involved in Refsum disease. , 2003, American journal of human genetics.
[13] N. Rotstein,et al. Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. , 2003, Investigative ophthalmology & visual science.
[14] H. Moser,et al. Peroxisomal disease cell lines with cellular plasmalogen deficiency have impaired muscarinic cholinergic signal transduction activity and amyloid precursor protein secretion. , 1998, Biochemical and biophysical research communications.
[15] H. Tabak,et al. Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1. , 2002, American journal of human genetics.
[16] L. Horrocks,et al. Plasmalogens, phospholipases A2 and signal transduction , 1995, Brain Research Reviews.
[17] K. Beckman,et al. Exclusive localization in peroxisomes of dihydroxyacetone phosphate acyltransferase and alkyl-dihydroxyacetone phosphate synthase in rat liver. , 1993, Journal of lipid research.
[18] D. Valle,et al. Peroxisome biogenesis disorders. , 2003, Annual review of genomics and human genetics.
[19] R. Brady,et al. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Gutteridge,et al. Lipid peroxidation and antioxidants as biomarkers of tissue damage. , 1995, Clinical chemistry.
[21] K. Wisniewski,et al. New subform of the late infantile form of neuronal ceroid lipofuscinosis. , 1993, Neuropediatrics.
[22] B. Rosner,et al. Plasma docosahexaenoic acid levels in various genetic forms of retinitis pigmentosa. , 1992, Investigative ophthalmology & visual science.
[23] Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns , 2002 .
[24] M. Ghosh,et al. Subcellular distribution and properties of acyl/alkyl dihydroxyacetone phosphate reductase in rodent livers. , 1986, Archives of biochemistry and biophysics.
[25] H. Moser,et al. Cerebellar atrophy in chronic rhizomelic chondrodysplasia punctata: a potential role for phytanic acid and calcium in the death of its Purkinje cells , 1999, Acta Neuropathologica.
[26] S Subramani,et al. Import of peroxisomal matrix and membrane proteins. , 2000, Annual review of biochemistry.
[27] M. Ghosh,et al. Purification and properties of acyl/alkyl dihydroxyacetone-phosphate reductase from guinea pig liver peroxisomes. , 1990, The Journal of biological chemistry.
[28] R. Wanders,et al. Genetic and biochemical heterogeneity in patients with the rhizomelic form of chondrodysplasia punctata — a complementation study , 1992, Human Genetics.
[29] Kai Simons,et al. Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.
[30] H. Hayashi,et al. Fatty alcohol synthesis accompanied with chain elongation in liver peroxisomes. , 1997, Biochimica et biophysica acta.
[31] R. Mcinnes,et al. Progress toward understanding the genetic and biochemical mechanisms of inherited photoreceptor degenerations. , 2003, Annual review of neuroscience.
[32] H. Goebel,et al. The Neuronal Ceroid‐Lipofuscinoses. Recent Advances , 1998, Brain pathology.
[33] A. Hajra. Dihydroxyacetone phosphate acyltransferase. , 1997, Biochimica et biophysica acta.
[34] P. Carmeliet,et al. A mouse model for Zellweger syndrome , 1997, Nature Genetics.
[35] S. Rapoport,et al. Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain , 1995, Brain Research.
[36] H. van den Bosch,et al. The native molecular size of alkyl-dihydroxyacetonephosphate synthase and dihydroxyacetonephosphate acyltransferase. , 1998, Biochimica et biophysica acta.
[37] L. Horrocks,et al. Book Review: Plasmalogens: Workhorse Lipids of Membranes in Normal and Injured Neurons and Glia , 2001 .
[38] H. Waterham,et al. Identification of human PMP34 as a peroxisomal ATP transporter. , 2002, Biochemical and biophysical research communications.
[39] R. Wanders,et al. The cerebro-hepato-renal (Zellweger) syndrome. Impaired de novo biosynthesis of plasmalogens in cultured skin fibroblasts. , 1985, Biochimica et biophysica acta.
[40] D. Johnson,et al. Rhizomelic chondrodysplasia punctata: clinical, pathologic, and biochemical findings in two patients. , 1988, The Journal of pediatrics.
[41] C. Haass,et al. Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts , 2003, The Journal of cell biology.
[42] J. Xuereb,et al. Membrane Instability, Plasmalogen Content, and Alzheimer's Disease , 1998, Journal of neurochemistry.
[43] C. Rock,et al. A short-chain acyl-CoA: 1-alkyl-2-acyl-sn-glycerol acyltrasnferase from a microsomal fraction of the rabbit Harderian gland. , 1975, Biochimica et biophysica acta.
[44] D. Kirschner,et al. Myelin labeled with mercuric chloride. Asymmetric localization of phosphatidylethanolamine plasmalogen. , 1982, Journal of molecular biology.
[45] D. Ford,et al. Activation of myocardial cAMP‐dependent protein kinase by lysoplasmenylcholine , 1997, FEBS letters.
[46] A. Das,et al. Induction of the Peroxisomal Glycerolipid-synthesizing Enzymes during Differentiation of 3T3-L1 Adipocytes , 2000, The Journal of Biological Chemistry.
[47] D. Portilla,et al. cDNA cloning and expression of a novel family of enzymes with calcium-independent phospholipase A2 and lysophospholipase activities. , 1998, Journal of the American Society of Nephrology : JASN.
[48] R. Zoeller,et al. Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport Published, JLR Papers in Press, November 4, 2002. DOI 10.1194/jlr.M200363-JLR200 , 2003, Journal of Lipid Research.
[49] J. Infante. Biosynthesis of acyl‐specific glycerophospholipids in mammalian tissues , 1984, FEBS letters.
[50] R. Wanders,et al. Alkyl-Dihydroxyacetonephosphate Synthase , 1998, The Journal of Biological Chemistry.
[51] C. Hübner,et al. Low erythrocyte plasmalogen and plasma docosahexaenoic acid (DHA) in juvenile neuronal ceroid-lipofuscinosis (JNCL) , 1993, Journal of Inherited Metabolic Disease.
[52] P. K. Chakraborty,et al. Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype , 2002, Human mutation.
[53] B. Engelmann,et al. Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro. , 1997, The Biochemical journal.
[54] G. Durand,et al. Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus , 2000, Neurobiology of Aging.
[55] M. Haltia. The Neuronal Ceroid–Lipofuscinoses , 2003, Journal of neuropathology and experimental neurology.
[56] F. Paltauf,et al. Ether lipids in biomembranes. , 1994, Chemistry and physics of lipids.
[57] J. Gunawan,et al. Lysoplasmalogenase–A Microsomal Enzyme from Rat Brain , 1982, Journal of neurochemistry.
[58] Xianlin Han,et al. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry , 2001, Journal of neurochemistry.
[59] U. Honegger,et al. Plasmalogen content and beta-adrenoceptor signalling in fibroblasts from patients with Zellweger syndrome. Effects of hexadecylglycerol. , 2002, Biochimica et biophysica acta.
[60] C. Leray,et al. Phospholipid composition in late infantile neuronal ceroid lipofuscinosis , 2000, European journal of clinical investigation.
[61] D. C. Mitchell,et al. DHA-rich phospholipids optimize G-Protein-coupled signaling. , 2003, The Journal of pediatrics.
[62] A. Hermetter,et al. Influence of plasmalogen deficiency on membrane fluidity of human skin fibroblasts: a fluorescence anisotropy study. , 1989, Biochimica et biophysica acta.
[63] R. Wanders,et al. Abnormal myelin formation in rhizomelic chondrodysplasia punctata type 2 (DHAPAT‐deficiency) , 2000, Developmental medicine and child neurology.
[64] D. Portilla,et al. Hypoxia-induced amphiphiles inhibit renal Na+, K(+)-ATPase. , 1996, Kidney international.
[65] G. Dallner,et al. Peroxisomal Impairment in Niemann-Pick Type C Disease* , 1997, The Journal of Biological Chemistry.
[66] R. Gross,et al. Rat and human pancreatic islet cells contain a calcium ion independent phospholipase A2 activity selective for hydrolysis of arachidonate which is stimulated by adenosine triphosphate and is specifically localized to islet beta-cells. , 1993, Biochemistry.
[67] T. Mock,et al. The catabolism of plasmenylcholine in the guinea pig heart. , 1986, The Biochemical journal.
[68] D. Portilla,et al. Purification of a Novel Calcium-independent Phospholipase A2 from Rabbit Kidney* , 1996, The Journal of Biological Chemistry.
[69] N. Nagan,et al. Plasmalogens: biosynthesis and functions. , 2001, Progress in lipid research.
[70] Klaus-Armin Nave,et al. Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice. , 2003, Human molecular genetics.
[71] B. Roelofsen,et al. Plasmalogen content and distribution in the sarcolemma of cultured neonatal rat myocytes , 1988, FEBS letters.
[72] M. Hims,et al. Retinitis pigmentosa: genes, proteins and prospects. , 2003, Developments in ophthalmology.
[73] P. Carmeliet,et al. Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata. , 2003, Human molecular genetics.
[74] D. Birch,et al. Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa. , 2001, Journal of lipid research.
[75] P. Fleming,et al. 1-Alkyl-sn-glycero-3-phosphate: acyl-CoA acyltransferase in rat brain microsomes. , 1977, The Journal of biological chemistry.
[76] D. Valle,et al. Peroxisome biogenesis disorders: genetics and cell biology. , 2000, Trends in genetics : TIG.
[77] V. Di Marzo. Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions. , 1995, Prostaglandins, leukotrienes, and essential fatty acids.
[78] A. Moser,et al. Biochemical abnormalities in rhizomelic chondrodysplasia punctata. , 1988, The Journal of pediatrics.
[79] A. Alkan,et al. Delayed myelination in a rhizomelic chondrodysplasia punctata case: MR spectroscopy findings. , 2003, Magnetic resonance imaging.
[80] J. Opitz,et al. Heterogeneity of Chondrodysplasia punctata , 2004, Humangenetik.
[81] L. Horrocks,et al. Solubilization, purification and characterization of lysoplasmalogen alkenylhydrolase (lysoplasmalogenase) from rat liver microsomes. , 1989, Biochimica et biophysica acta.
[82] V. Marzo. Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions. , 1995 .
[83] B. Engelmann,et al. Role of plasmalogens in the enhanced resistance of LDL to copper-induced oxidation after LDL apheresis. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[84] E. Gottfried,et al. Hereditary nonspherocytic hemolytic disease associated with an altered phospholipid composition of the erythrocytes. , 1968, The Journal of clinical investigation.
[85] S. Hazen,et al. Purification and characterization of canine myocardial cytosolic phospholipase A2. A calcium-independent phospholipase with absolute f1-2 regiospecificity for diradyl glycerophospholipids. , 1990, The Journal of biological chemistry.
[86] F. Snyder,et al. Ether-Linked Glycerolipids and Their Bioactive Species:Enzymes and Metabolic Regulation , 1985 .
[87] H. Waterham,et al. Biochemical markers predicting survival in peroxisome biogenesis disorders , 2002, Neurology.
[88] H. Goebel. The neuronal ceroid-lipofuscinoses. , 1995, Journal of child neurology.
[89] B. Landing,et al. Studies of vertebral coronal cleft in rhizomelic chondrodysplasia punctata. , 1992, Pediatric pathology.
[90] R. Wanders,et al. Etherphospholipid biosynthesis and dihydroxyactetone-phosphate acyltransferase: resolution of the genomic organization of the human gnpat gene and its use in the identification of novel mutations. , 2001, Biochemical and biophysical research communications.
[91] Anthony N. Martonosi,et al. The Enzymes of Biological Membranes , 1985, Springer US.
[92] M. Rüdiger,et al. Plasmalogens effectively reduce the surface tension of surfactant-like phospholipid mixtures. , 1998, The American journal of physiology.
[93] K. Hofmann,et al. Effect of cholesterol and surfactant protein B on the viscosity of phospholipid mixtures. , 2002, Chemistry and physics of lipids.
[94] G. Kay,et al. Pex13 Inactivation in the Mouse Disrupts Peroxisome Biogenesis and Leads to a Zellweger Syndrome Phenotype , 2003, Molecular and Cellular Biology.
[95] G. Spiteller,et al. Lipid oxidation products in ischemic porcine heart tissue. , 1996, Chemistry and physics of lipids.
[96] K. Lohner,et al. Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes? , 1996, Chemistry and physics of lipids.
[97] I. Singh,et al. Intraperoxisomal localization of very-long-chain fatty acyl-CoA synthetase: implication in X-adrenoleukodystrophy. , 2000, Experimental cell research.
[98] R. G. Holmes,et al. Zellweger syndrome: diagnostic assays, syndrome delineation, and potential therapy. , 1986, American journal of medical genetics.
[99] R. Wanders,et al. Acyl-CoA:dihydroxyacetonephosphate acyltransferase: cloning of the human cDNA and resolution of the molecular basis in rhizomelic chondrodysplasia punctata type 2. , 1998, Human molecular genetics.
[100] H. Moser,et al. Genetic and Phenotypic Heterogeneity in Disorders of Peroxisome Biogenesis—A Complementation Study Involving Cell Lines from 19 Patients , 1989, Pediatric Research.
[101] E. D. de Vet,et al. Nucleotide sequence of human alkyl-dihydroxyacetonephosphate synthase cDNA reveals the presence of a peroxisomal targeting signal 2. , 1997, Biochimica et biophysica acta.
[102] L. Horrocks,et al. Plasmalogen-selective phospholipase A2 and its role in signal transduction. , 1996, Journal of lipid mediators and cell signalling.
[103] F. Opperdoes,et al. Cloning and characterization of the NAD-linked glycerol-3-phosphate dehydrogenases of Trypanosoma brucei brucei and Leishmania mexicana mexicana and expression of the trypanosome enzyme in Escherichia coli. , 1996, Molecular and biochemical parasitology.
[104] R. Zoeller,et al. Plasmalogen status influences docosahexaenoic acid levels in a macrophage cell line. Insights using ether lipid-deficient variants. , 1999, Journal of lipid research.
[105] L. Binaglia,et al. Purification of ethanolaminephosphotransferase from bovine liver microsomes. , 1999, Biochimica et biophysica acta.
[106] A. Hajra,et al. GLYCEROLIPID BIOSYNTHESIS IN PEROXISOMES VIA THE ACYL DIHYDROXYACETONE PHOSPHATE PATHWAY * , 1982, Annals of the New York Academy of Sciences.
[107] M. Bennett,et al. Juvenile neuronal ceroid-lipofuscinosis: Characterization of the dyslipoproteinaemia and demonstration of membrane phospholipid and phospholipid-dependent signal transduction abnormalities in cultured skin fibroblasts , 1993, Journal of Inherited Metabolic Disease.
[108] F. Snyder,et al. Alkyldihydroxyacetone-P synthase. Solubilization, partial purification, new assay method, and evidence for a ping-pong mechanism. , 1982, The Journal of biological chemistry.
[109] A. Moser,et al. Impaired membrane traffic in defective ether lipid biosynthesis. , 2001, Human molecular genetics.
[110] P. Watkins,et al. Human liver-specific very-long-chain acyl-coenzyme A synthetase: cDNA cloning and characterization of a second enzymatically active protein. , 1999, Molecular genetics and metabolism.
[111] B. Rosner,et al. Red blood cell membrane phosphatidylethanolamine fatty acid content in various forms of retinitis pigmentosa. , 1995, Journal of lipid research.
[112] W. Lieberthal,et al. Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether. , 1999, The Biochemical journal.
[113] A. Hermetter,et al. Stabilization of non-bilayer structures by the etherlipid ethanolamine plasmalogen. , 1991, Biochimica et biophysica acta.
[114] P. Stevens,et al. Synthesis and secretion of plasmalogens by type-II pneumocytes. , 1994, The Biochemical journal.
[115] M. Hatten,et al. Targeted Deletion of the PEX2 Peroxisome Assembly Gene in Mice Provides a Model for Zellweger Syndrome, a Human Neuronal Migration Disorder , 1997, The Journal of cell biology.
[116] K. Webber,et al. Dihydroxyacetone phosphate acyltransferase. , 1992, Methods in enzymology.
[117] R. Wanders,et al. Alkyl-dihydroxyacetone phosphate synthase and dihydroxyacetone phosphate acyltransferase form a protein complex in peroxisomes. , 1999, European journal of biochemistry.
[118] Xianlin Han,et al. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. , 2002, Biochemistry.
[119] K. Wisniewski,et al. Abnormal processing of carboxy-terminal fragment of beta precursor protein (βPP) in neuronal ceroid-lipofuscinosis (NCL) cases , 1993, Journal of Inherited Metabolic Disease.
[120] P. Henkind,et al. Pathology of retinitis pigmentosa. , 1982, Ophthalmology.
[121] S. Hazen,et al. The rapid and reversible activation of a calcium-independent plasmalogen-selective phospholipase A2 during myocardial ischemia. , 1991, The Journal of clinical investigation.
[122] H. Bosch,et al. Nucleotide sequence of human alkyl-dihydroxyacetonephosphate synthase cDNA reveals the presence of a peroxisomal targeting signal 2 , 1997 .
[123] R. Dluhy,et al. Identification of phosphocholine plasmalogen as a lipid component in mammalian pulmonary surfactant using high-resolution 31P NMR spectroscopy. , 1993, Biochemistry.
[124] F. Snyder,et al. Effects of eicosapentaenoic and docosahexaenoic acid supplements on phospholipid composition and plasmalogen biosynthesis in P388D1 cells. , 1989, Archives of biochemistry and biophysics.
[125] F. Snyder,et al. Biosynthesis of choline plasmalogens in neonatal rat myocytes. , 1991, Archives of biochemistry and biophysics.
[126] R. Brady,et al. Niemann-Pick type-C disease: deficient intracellular transport of exogenously derived cholesterol. , 1992, American journal of medical genetics.
[127] R. Gross,et al. Alterations in membrane dynamics elicited by amphiphilic compounds are augmented in plasmenylcholine bilayers. , 1991, Biochimica et biophysica acta.
[128] R. Gross,et al. Plasmenylethanolamine facilitates rapid membrane fusion: a stopped-flow kinetic investigation correlating the propensity of a major plasma membrane constituent to adopt an HII phase with its ability to promote membrane fusion. , 1994, Biochemistry.
[129] E. Wiemer,et al. Kinetics of the assembly of peroxisomes after fusion of complementary cell lines from patients with the cerebro-hepato-renal (Zellweger) syndrome and related disorders. , 1988, Biochemical and biophysical research communications.
[130] M. Creer,et al. Selective hydrolysis of plasmalogen phospholipids by Ca 2 1-independent PLA 2 in hypoxic ventricular myocytes , 1998 .
[131] J. Ranjeva,et al. MR imaging and MR spectroscopy in rhizomelic chondrodysplasia punctata. , 2002, AJNR. American journal of neuroradiology.
[132] L. Horrocks,et al. Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. , 2001, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[133] N. Weber,et al. Biosynthesis and biotransformation of ether lipids , 1987, Lipids.
[134] R. Zoeller,et al. Increasing plasmalogen levels protects human endothelial cells during hypoxia. , 2002, American journal of physiology. Heart and circulatory physiology.
[135] Carlo Rivolta,et al. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. , 2002, Human molecular genetics.
[136] S. Rapoport,et al. Phospholipid composition and levels are altered in down syndrome brain , 2000, Brain Research.
[137] L. Horrocks,et al. Characterization of plasmalogen-selective phospholipase A2 from bovine brain. , 1996, Advances in experimental medicine and biology.
[138] D. Ford,et al. Plasmenylethanolamine is the major storage depot for arachidonic acid in rabbit vascular smooth muscle and is rapidly hydrolyzed after angiotensin II stimulation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[139] G. Dallner,et al. The protective role of plasmalogens in iron-induced lipid peroxidation. , 1999, Free radical biology & medicine.
[140] S. Rapoport,et al. 85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain. , 1999, Neuroreport.